# COCHW (Envoy Medical, Inc.) - SEC EDGAR Financial Statements

> Envoy Medical, Inc. reported $231K in revenue and a net loss of $20.85M for the trailing twelve months ended September 30, 2026 (up 57.1% year over year), with a -352.8% gross margin and a -10343.3% operating margin.

- Canonical: https://convexityos.com/fundamentals/COCHW
- Markdown: https://convexityos.com/fundamentals/COCHW.md
- SEC CIK: 0001840877
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:52 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001840877&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $231K | +57.1% YoY |
| Operating Income | TTM | -$23.89M | -10343.3% margin |
| Net Income | TTM | -$20.85M | -9026.4% net margin |
| Diluted EPS | TTM | -$2.00 | Split-adjusted |
| Free Cash Flow | TTM | -$18.38M | -7956.7% FCF margin |
| Cash & ST Investments | Sep 30, 2026 | $14.57M | Total debt: -- |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| --- | --- | --- | --- | --- | --- |
| **Revenue** | $241K | $225K | $316K | $237K | -- |
| Cost of Revenue | $874K | $742K | $789K | $498K | -- |
| **Gross Profit** | -$633K | -$517K | -$473K | -$261K | -- |
| Research & Development | $12.49M | $10.18M | $8.96M | $4.97M | -- |
| Selling, General & Admin | $9.15M | $8.56M | $7.28M | $2.58M | -- |
| **Operating Income** | -$22.27M | -$19.26M | -$18.36M | -$8.71M | -$5.20M |
| **EBITDA** | -$21.97M | -$19.08M | -$18.23M | -$8.63M | -- |
| Interest Income | -- | -- | -- | $6.13M | $38K |
| Interest Expense | $1.59M | $816K | -- | -- | -- |
| Income Before Tax | -$23.76M | -$20.80M | -- | $20.74M | -$252K |
| Income Tax Expense | -- | -- | -- | $1.50M | -- |
| **Net Income** | -$23.76M | -$20.80M | -$29.92M | -$15.92M | -$252K |
| Basic EPS | -$12.30 | -$14.90 | -$25.40 | -$15.70 | -- |
| **Diluted EPS** | -$12.30 | -$14.90 | -$25.40 | -$15.70 | -- |
| Basic Shares Outstanding | 2.3M | 1.9M | 1.2M | 1.0M | -- |
| Diluted Shares Outstanding | 2.3M | 1.9M | 1.2M | 1.0M | -- |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $66K | $51K | $39K | $75K | $42K | $78K | $46K | $42K |
| Cost of Revenue | $244K | $278K | $313K | $211K | $203K | $234K | $226K | $157K |
| **Gross Profit** | -$178K | -$227K | -$274K | -$136K | -$161K | -$156K | -$180K | -$115K |
| Research & Development | $3.08M | $3.13M | $3.64M | $4.55M | $2.70M | $2.48M | $2.75M | $2.47M |
| Selling, General & Admin | $2.28M | $2.21M | $2.04M | $2.14M | $2.40M | $2.43M | $2.18M | $1.96M |
| **Operating Income** | -$5.54M | -$5.57M | -$5.96M | -$6.83M | -$5.26M | -$5.07M | -$5.11M | -$4.55M |
| **EBITDA** | -$5.46M | -$5.50M | -$5.89M | -$6.75M | -$5.19M | -$4.99M | -$5.05M | -$4.50M |
| Interest Expense | -- | -- | -- | $0 | $471K | $624K | $495K | $384K |
| **Net Income** | -$3.93M | -$5.98M | -$4.35M | -$6.59M | -$6.48M | -$5.69M | -$5.00M | -$4.62M |
| Basic EPS | -$0.50 | -$0.70 | -$0.80 | -- | -$3.55 | -$3.20 | -$2.90 | -- |
| **Diluted EPS** | -$0.50 | -$0.70 | -$0.80 | -- | -$3.55 | -$3.20 | -$2.90 | -- |
| Basic Shares Outstanding | 10.4M | 10.4M | 6.9M | -- | 2.2M | 2.1M | 2.1M | -- |
| Diluted Shares Outstanding | 10.4M | 10.4M | 6.9M | -- | 2.2M | 2.1M | 2.1M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $3.74M | $5.48M | $4.22M | $183K | $150K | $25K |
| **Cash & Short-Term Investments** | $3.74M | $5.48M | $4.22M | $183K | $150K | $25K |
| Accounts Receivable, Net | $34K | $38K | $70K | $41K | -- | -- |
| Inventory | $1.55M | $1.71M | $1.40M | $1.29M | -- | -- |
| **Total Current Assets** | $6.28M | $8.90M | $7.46M | $1.65M | $863K | $25K |
| Property, Plant & Equipment, Net | $1.03M | $1.27M | $351K | $331K | -- | -- |
| **Total Non-Current Assets** | $2.28M | $2.64M | $815K | $908K | $426.0M | $95K |
| **Total Assets** | $8.56M | $11.54M | $8.27M | $2.56M | $426.9M | $120K |
| Accounts Payable | $2.92M | $1.65M | $1.55M | $1.00M | $619K | $96K |
| Other Current Liabilities | $518K | $573K | $645K | -- | -- | -- |
| **Total Current Liabilities** | $11.56M | $7.54M | $7.29M | $2.52M | $2.68M | $96K |
| Other Non-Current Liabilities | $27K | $891K | -- | $127K | -- | -- |
| **Total Non-Current Liabilities** | $8.76M | $22.84M | $2.76M | $36.23M | $35.94M | $0 |
| **Total Liabilities** | $20.32M | $30.38M | $10.05M | $38.75M | $38.62M | $96K |
| **Total Debt (incl. Leases)** | $919K | $945K | $600K | -- | -- | -- |
| Common Stock | $3.0K | $2.0K | -- | -- | -- | -- |
| Retained Earnings | -$313.4M | -$284.7M | -$257.3M | -$226.0M | -$36.71M | -$701 |
| Accumulated Other Comp. Income | -$120K | -$123K | -$118K | -$115K | -- | -- |
| **Total Stockholders' Equity** | -$12.16M | -$18.84M | -$1.78M | -$36.20M | -$44.96M | $24K |
| Total Equity | -$12.16M | -$18.84M | -$1.78M | -$36.20M | -$44.96M | $24K |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $14.57M | $19.68M | $25.25M | $3.74M | $3.56M | $5.30M | $5.30M | $5.48M |
| **Cash & Short-Term Investments** | $14.57M | $19.68M | $25.25M | $3.74M | $3.56M | $5.30M | $5.30M | $5.48M |
| Accounts Receivable, Net | $51K | $49K | $31K | $34K | $35K | $43K | $42K | $38K |
| Inventory | $1.51M | $1.58M | $1.49M | $1.55M | $1.64M | $1.59M | $1.66M | $1.71M |
| **Total Current Assets** | $17.26M | $21.92M | $27.68M | $6.28M | $5.76M | $7.51M | $8.31M | $8.90M |
| Property, Plant & Equipment, Net | $854K | $921K | $962K | $1.03M | $1.12M | $1.14M | $1.22M | $1.27M |
| **Total Non-Current Assets** | $1.90M | $2.03M | $2.14M | $2.28M | $2.42M | $2.39M | $2.07M | $2.64M |
| **Total Assets** | $19.16M | $23.95M | $29.82M | $8.56M | $8.18M | $9.90M | $10.38M | $11.54M |
| Accounts Payable | $1.58M | $2.04M | $1.70M | $2.92M | $2.68M | $1.62M | $1.66M | $1.65M |
| Other Current Liabilities | $650K | $166K | $379K | $518K | $13K | $179K | $415K | $573K |
| **Total Current Liabilities** | $14.27M | $12.63M | $12.21M | $11.56M | $8.99M | $8.00M | $7.59M | $7.54M |
| Other Non-Current Liabilities | $27K | $27K | $27K | $27K | $891K | $891K | $891K | $891K |
| **Total Non-Current Liabilities** | $6.03M | $7.62M | $7.06M | $8.76M | $6.72M | $31.76M | $27.01M | $22.84M |
| **Total Liabilities** | $20.30M | $20.25M | $19.27M | $20.32M | $15.71M | $39.76M | $34.61M | $30.38M |
| **Total Debt (incl. Leases)** | -- | -- | -- | $919K | -- | -- | $923K | $945K |
| Common Stock | $8.0K | $8.0K | $8.0K | $3.0K | $2.0K | $2.0K | $2.0K | $2.0K |
| Retained Earnings | -$331.6M | -$326.4M | -$319.1M | -$313.4M | -$305.7M | -$297.9M | -$291.0M | -$284.7M |
| Accumulated Other Comp. Income | -$123K | -$122K | -$121K | -$120K | -$120K | -$119K | -$117K | -$123K |
| **Total Stockholders' Equity** | -$1.53M | $3.30M | $10.16M | -$12.16M | -$7.66M | -$29.86M | -$24.22M | -$18.84M |
| Total Equity | -$1.53M | $3.30M | $10.16M | -$12.16M | -$7.66M | -$29.86M | -$24.22M | -$18.84M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| --- | --- | --- | --- | --- | --- |
| Net Income | -$23.76M | -$20.80M | -$29.92M | $19.23M | -$252K |
| Depreciation & Amortization | $302K | $173K | $133K | $75K | -- |
| Stock-Based Compensation | $657K | $562K | $1.57M | $0 | -- |
| Change in Receivables | $4.0K | $32K | -$29K | $47K | -- |
| Change in Inventory | $126K | -$380K | -$10K | -$194K | -- |
| Change in Payables | $1.39M | -$19K | $551K | $342K | $618K |
| **Operating Cash Flow** | -$18.20M | -$17.95M | -$17.09M | -$8.80M | -$3.24M |
| Capital Expenditure | -$179K | -$980K | -$153K | -$218K | -- |
| **Free Cash Flow** | -$18.38M | -$18.93M | -$17.24M | -$9.02M | -- |
| **Investing Cash Flow** | -$179K | -$980K | -$153K | -$218K | -$425.0M |
| Common Stock Issued | $414K | -- | $109K | -- | -- |
| Dividends Paid | -$1.82M | -$2.45M | -- | -- | -- |
| **Financing Cash Flow** | $16.63M | $20.20M | $21.28M | $8.09M | $428.4M |
| **Net Change in Cash** | -$1.74M | $1.26M | $4.04M | -$938K | $125K |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$3.93M | -$5.98M | -$4.35M | -$6.59M | -$6.48M | -$5.69M | -$5.00M | -$4.62M |
| Depreciation & Amortization | $75K | $74K | $73K | $80K | $76K | $85K | $61K | $48K |
| Stock-Based Compensation | $307K | $214K | $239K | $179K | $172K | $146K | $160K | $153K |
| Change in Receivables | -$2.0K | -$18K | $3.0K | $1.0K | $8.0K | -$1.0K | -$4.0K | $159K |
| Change in Inventory | $85K | -$103K | $44K | $125K | -$110K | $37K | $74K | -$143K |
| Change in Payables | -$433K | $308K | -$1.22M | $412K | $1.01M | -$43K | $10K | -$222K |
| **Operating Cash Flow** | -$5.03M | -$5.46M | -$6.06M | -$5.68M | -$4.33M | -$4.46M | -$3.73M | -$5.09M |
| Capital Expenditure | -- | -- | -- | -$172K | $0 | -$1.0K | -$6.0K | -- |
| **Free Cash Flow** | -- | -- | -- | -$5.86M | -$4.33M | -$4.46M | -$3.73M | -- |
| **Investing Cash Flow** | -- | -- | -- | -$172K | $0 | -$1.0K | -$6.0K | $534K |
| Common Stock Issued | $0 | $0 | $30.00M | -- | -- | -- | -- | -- |
| Dividends Paid | -- | -- | -- | $1.0K | $0 | -$607K | -$1.21M | -- |
| **Financing Cash Flow** | -$51K | -$109K | $27.57M | $6.04M | $2.60M | $4.44M | $3.55M | $5.62M |
| **Net Change in Cash** | -$5.11M | -$5.57M | $21.51M | $183K | -$1.73M | -$25K | -$171K | $1.06M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| --- | --- | --- | --- | --- | --- |
| **Gross Margin** | -262.7% | -229.8% | -149.7% | -110.1% | -- |
| **Operating Margin** | -9240.7% | -8558.2% | -5809.8% | -3673.4% | -- |
| **Net Profit Margin** | -9857.3% | -9242.2% | -9469.0% | -6718.6% | -- |
| Return on Assets (ROA) | -277.6% | -180.2% | -361.8% | -623.0% | -0.1% |
| Current Ratio | 0.54x | 1.18x | 1.02x | 0.65x | 0.32x |
| Quick Ratio | 0.41x | 0.95x | 0.83x | 0.14x | 0.06x |
| **Revenue Growth (YoY)** | +7.1% | -28.8% | +33.3% | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | -352.8% | -385.5% | -310.7% | -262.7% | -294.2% | -262.2% | -284.4% | -229.8% |
| **Operating Margin** | -10343.3% | -11411.1% | -9881.2% | -9240.7% | -9611.1% | -8873.0% | -9188.7% | -8558.7% |
| **Net Profit Margin** | -9026.4% | -11304.8% | -9875.6% | -9857.3% | -10475.0% | -9579.3% | -9209.0% | -9242.2% |
| Return on Equity (ROE) | -- | -708.5% | -227.4% | -- | -- | -- | -- | -- |
| Return on Assets (ROA) | -108.8% | -97.7% | -77.5% | -277.6% | -266.3% | -214.8% | -188.0% | -180.2% |
| Current Ratio | 1.21x | 1.73x | 2.27x | 0.54x | 0.64x | 0.94x | 1.09x | 1.18x |
| Quick Ratio | 1.10x | 1.61x | 2.14x | 0.41x | 0.46x | 0.74x | 0.88x | 0.95x |
| **Revenue Growth (YoY)** | +57.1% | -34.6% | -15.2% | +78.6% | -25.0% | +14.7% | -22.0% | -55.8% |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
